1333331-93-3 Usage
Uses
Used in Pharmaceutical Industry:
1-(3H-benzo[d]imidazol-4-yl)-5-hydroxy-2-methylpyridin-4(1H)-one is used as a potential antiviral and antitumor agent for its pharmacological activities. Its unique chemical structure allows it to be a candidate for drug development, particularly in the treatment of viral infections and various types of cancer.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 1-(3H-benzo[d]imidazol-4-yl)-5-hydroxy-2-methylpyridin-4(1H)-one is used as a compound for further study and development. Its fusion of benzimidazole and pyridine rings, along with the hydroxyl and methyl groups, provides a foundation for exploring new drug candidates and understanding their mechanisms of action.
Used in Pharmacology Studies:
1-(3H-benzo[d]imidazol-4-yl)-5-hydroxy-2-methylpyridin-4(1H)-one is utilized in pharmacology studies to investigate its potential effects on biological systems. 1-(3H-benzo[d]imidazol-4-yl)-5-hydroxy-2-methylpyridin-4(1H)-one's antiviral and antitumor properties make it an interesting subject for research into new therapeutic approaches and understanding its interactions with various cellular targets.
Check Digit Verification of cas no
The CAS Registry Mumber 1333331-93-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,3,3,3,3 and 1 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1333331-93:
(9*1)+(8*3)+(7*3)+(6*3)+(5*3)+(4*3)+(3*1)+(2*9)+(1*3)=123
123 % 10 = 3
So 1333331-93-3 is a valid CAS Registry Number.
1333331-93-3Relevant academic research and scientific papers
INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS
-
Page/Page column 138, (2011/10/03)
The present invention relates to 4-pyridinone compounds which are inhibitors of catechol O-methyltransferase (COMT), and are useful in the treatment and prevention of neurological and psychiatric disorders and diseases in which COMT enzyme is involved. The present invention also relates to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which COMT is involved
